Header image

Poster Tour: Basic Science

Thursday, September 19, 2019
12:15 PM - 12:45 PM

Speaker

Mr Damien Fagan
Associate Director, Medical Affairs
Gilead Sciences Pty Ltd

#6 HIGH LEVEL OF PRE-EXISTING NRTI RESISTANCE PRIOR TO SWITCHING TO BIC/FTC/TAF (STUDY 4030)

12:15 PM - 12:20 PM

Abstract

Biography

Mr Damien Fagan
Associate Director, Medical Affairs
Gilead Sciences Pty Ltd

#4 LONG TERM B/F/TAF SWITCH EFFICACY IN PATIENTS WITH ARCHIVED PREEXISTING RESISTANCE

12:20 PM - 12:25 PM

Abstract

Biography

Mr Damien Fagan
Associate Director, Medical Affairs
Gilead Sciences Pty Ltd

#5 FORGIVENESS OF ANTIRETROVIRAL REGIMENS: IN VITRO HIV-1 VIRAL BREAKTHROUGH WITH 2-DRUG VERSUS 3-DRUG REGIMENS SIMULATING VARIABLE ADHERENCE TO TREATMENT

12:25 PM - 12:30 PM

Abstract

Biography

Lloyd DÓrsogna

#3 ABACAVIR INDUCED ALLOREACTIVITY: RELEVANCE TO KIDNEY TRANSPLANTATION FOR HIV POSITIVE INDIVIDUALS

12:30 PM - 12:35 PM

Abstract

Biography

Lloyd DÓrsogna

#2 HIV-SPECIFIC T CELL CLONOTYPES MAY CONTRIBUTE TO THE ABACAVIR DRUG HYPERSENSITIVITY REACTION VIA HETEROLOGOUS IMMUNITY

12:35 PM - 12:40 PM

Abstract

Biography


Facilitator

Patricia Price
Principal Research Fellow
Curtin university

loading